These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15255814)

  • 1. Prejunctional AT(1) receptor subtype-dependent modification of neurotransmitter releases in canine isolated splenic arteries.
    Komiyama J; Yang XP; Chiba S
    Auton Autacoid Pharmacol; 2003; 23(5-6):297-305. PubMed ID: 15255814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor subtypes involved in the modulation of purinergic and adrenergic vasoconstrictions to periarterial electrical nerve stimulation in the canine splenic artery.
    Yang XP; Chiba S
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S49-52. PubMed ID: 12688396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
    Muller C; Endlich K; Barthelmebs M; Helwig JJ
    Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prejunctional alpha adrenoceptor and angiotensin receptor function in isolated human, monkey and dog arteries.
    Toda N; Inoue S; Okunishi H
    J Pharmacol Exp Ther; 1988 Aug; 246(2):662-6. PubMed ID: 2841452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of omega-conotoxin GVIA and diltiazem on double peaked vasoconstrictor responses to periarterial electric nerve stimulation in isolated canine splenic artery.
    Yang XP; Chiba S
    Br J Pharmacol; 2000 Jan; 129(1):47-52. PubMed ID: 10694201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Existence of different alpha(1)-adrenoceptor subtypes in junctional and extrajunctional neurovascular regions in canine splenic arteries.
    Yang XP; Chiba S
    Br J Pharmacol; 2001 Apr; 132(8):1852-8. PubMed ID: 11309258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent systemic and renal haemodynamic effects of angiotensin II in conscious lambs: role of angiotensin AT1 and AT2 receptors.
    Chappellaz ML; Smith FG
    Exp Physiol; 2005 Nov; 90(6):837-45. PubMed ID: 16091404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor subtype 1 mediates angiotensin II enhancement of isoproterenol-induced cyclic AMP production in preglomerular microvascular smooth muscle cells.
    Inoue T; Mi Z; Gillespie DG; Dubey RK; Jackson EK
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1229-34. PubMed ID: 10027863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model.
    Nap A; Belterman CN; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):220-7. PubMed ID: 14689369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
    Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement by exogenous and locally generated angiotensin II of purinergic neurotransmission via angiotensin type 1 receptor in the guinea-pig isolated mesenteric artery.
    Onaka U; Fujii K; Abe I; Fujishima M
    Br J Pharmacol; 1997 Nov; 122(5):942-8. PubMed ID: 9384513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 receptor activation increases microvascular hydraulic permeability.
    Newton CR; Curran B; Victorino GP
    Surgery; 2004 Nov; 136(5):1054-60. PubMed ID: 15523401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prolonged cold storage on double peaked vasoconstrictor responses to periarterial nerve stimulation in isolated canine splenic arteries.
    Yang XP; Chiba S
    Br J Pharmacol; 1999 Apr; 126(8):1810-4. PubMed ID: 10372824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II enhances the afferent arteriolar response to adenosine through increases in cytosolic calcium.
    Lai EY; Patzak A; Persson AE; Carlström M
    Acta Physiol (Oxf); 2009 Aug; 196(4):435-45. PubMed ID: 19141138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
    Igarashi M; Hirata A; Nozaki H; Kadomoto-Antsuki Y; Tominaga M
    Diabetes Res Clin Pract; 2007 Mar; 75(3):267-77. PubMed ID: 16934905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation.
    Lu C; Su LY; Lee RM; Gao YJ
    Eur J Pharmacol; 2008 Jul; 589(1-3):188-93. PubMed ID: 18538762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y inhibits double peaked vasoconstrictor responses to periarterial nerve stimulation primarily through prejunctional Y2 receptor subtype in canine splenic arteries.
    Yang XP; Chiba S
    Auton Autacoid Pharmacol; 2002 Apr; 22(2):119-26. PubMed ID: 12568129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II inhibition of Ca2+ currents is independent of ATR1 angiotensin II receptor activation in rat adult vagal afferent neurons.
    Moreira TH; Rodrigues AL; Beirão PS; dos Santos RA; Santos Cruz J
    Auton Neurosci; 2005 Feb; 117(2):79-86. PubMed ID: 15664560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
    Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M
    Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-mediated inhibition of renal Ca2+ ATPase by physiological concentrations of angiotensin II is reversed by AT1- and AT2-receptor antagonists.
    Assunção-Miranda I; Guilherme AL; Reis-Silva C; Costa-Sarmento G; Oliveira MM; Vieyra A
    Regul Pept; 2005 Apr; 127(1-3):151-7. PubMed ID: 15680481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.